about
Development and validation of TLC-densitometric method for determination of lipid A adjuvant as a bulk and in solid fat nanoemulsions.Nanosolvated microtubule-modulating chemotherapeutics: a case-to-case study.Proteins and peptides: The need to improve them as promising therapeutics for ulcerative colitis.Nanoparticulate mediated transcutaneous immunization: Myth or reality.Vincristine sulfate loaded dextran microspheres amalgamated with thermosensitive gel offered sustained release and enhanced cytotoxicity in THP-1, human leukemia cells: In vitro and in vivo study.Immunological evaluation of colonic delivered Hepatitis B surface antigen loaded TLR-4 agonist modified solid fat nanoparticles.Stealth lipid coated aquasomes bearing recombinant human interferon-α-2b offered prolonged release and enhanced cytotoxicity in ovarian cancer cells.Inhalable nanostructured lipid particles of 9-bromo-noscapine, a tubulin-binding cytotoxic agent: in vitro and in vivo studies.Non-aggregated protamine-coated poly(lactide-co-glycolide) nanoparticles of cisplatin crossed blood-brain barrier, enhanced drug delivery and improved therapeutic index in glioblastoma cells: in vitro studies.Sterically stabilized gelatin microassemblies of noscapine enhance cytotoxicity, apoptosis and drug delivery in lung cancer cells.Poly (ethylene)-glycol conjugated solid lipid nanoparticles of noscapine improve biological half-life, brain delivery and efficacy in glioblastoma cells.Comparative study of transfersomes, liposomes, and niosomes for topical delivery of 5-fluorouracil to skin cancer cells: preparation, characterization, in-vitro release, and cytotoxicity analysis.Galactosylated gelatin nanovectors of doxorubicin inhibit cell proliferation and induce apoptosis in hepatocarcinoma cells.Evaluation of ISCOMs for immunization against hepatitis B.Targeted novel surface-modified nanoparticles for interferon delivery for the treatment of hepatitis B.Development, in vitro and in vivo characterization of Eudragit RL 100 nanoparticles for improved ocular bioavailability of acetazolamide."Prevention of structural perturbation and aggregation of hepatitis B surface antigen: screening of various additives".Evaluation of neuropeptide loaded trimethyl chitosan nanoparticles for nose to brain delivery.Evaluation of ISCOM vaccines for mucosal immunization against hepatitis B.Inhalable bioresponsive chitosan microspheres of doxorubicin and soluble curcumin augmented drug delivery in lung cancer cells.Evaluation of ISCOM matrices clearance from rabbit nasal cavity by γ scintigraphy.Tetanus toxoid-loaded cationic non-aggregated nanostructured lipid particles triggered strong humoral and cellular immune responses.Improved cisplatin delivery in cervical cancer cells by utilizing folate-grafted non-aggregated gelatin nanoparticles.Intravaginal administration of metformin hydrochloride loaded cationic niosomes amalgamated with thermosensitive gel for the treatment of polycystic ovary syndrome: In vitro and in vivo studies.Inclusion complex of colchicine in hydroxypropyl-β-cyclodextrin tenders better solubility and improved pharmacokineticsCarbohydrate modified ultrafine ceramic nanoparticles for allergen immunotherapyControlling release of metformin HCl through incorporation into stomach specific floating alginate beads
P50
Q35566418-F1DCC7AA-B14A-4AB2-84B9-3CB9808962E2Q38081688-DCD5FD6A-0E17-4392-B6E2-39D9490A1EBAQ38266101-D8A27C2A-B69E-49F3-A184-A469C7A469D6Q38696634-62EEBA14-8187-4159-BA28-5B81C7553C98Q38797197-2CF21BC5-1343-451E-A34D-55B85C83DFCCQ38831209-E8FB1D91-ABEE-4EAC-815B-A64B6C47F6D1Q38911877-0370EA31-25A3-4083-B768-046E2D9E03A8Q38916437-4124691C-7CBC-4B53-84E3-F512AAE51D31Q38981407-30E284AC-FE3F-4644-8229-696F095BA1BBQ39179736-C8B75A8A-865F-45EC-954B-9AD14C4C42E3Q39250790-3015CC0F-693C-4926-842B-25CB5D377D02Q39498830-67B46BD6-5635-4486-9C34-D3BBE74B458DQ39642456-35BD84F4-0552-44A7-BDC1-C43EC42F3FBFQ43277080-7E810764-3DC7-4B1B-BE94-D01F4BB5C831Q43534195-554BF4ED-4E6A-43C7-B941-C00772CE5D9CQ44908210-05D975C0-B40D-4BF1-931E-6FE9F90057CDQ44989827-CD95E6BA-F5A1-4B32-89E7-CFBCD2497776Q45344566-729899F7-183C-4153-9CFA-26D865EBCAD2Q46816112-671D2B6B-651F-446F-9A58-EA1225914BADQ51165416-92C8609B-315B-4C58-A199-48774ECC340CQ51548857-07DEB046-E286-4882-8383-1D54138B363DQ53127398-BE8580FF-6D73-493A-BB18-E4F76E6DC67AQ53623414-4BB4DCA9-2C47-466E-8BCD-9CE459E0CEEDQ55025376-072062A8-845C-4E19-B5CD-D17C97276D6CQ57183864-A2D366EB-FB2A-4D6D-908D-C6BD3FB79CC1Q58865828-FD7482AB-E4DC-4268-A266-24E29482794EQ82137775-1187B638-D615-4D95-86CD-03FEB3D1A461
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Ravi S Pandey
@es
Ravi S Pandey
@nl
Ravi S Pandey
@sl
Ravi S. Pandey
@en
type
label
Ravi S Pandey
@es
Ravi S Pandey
@nl
Ravi S Pandey
@sl
Ravi S. Pandey
@en
prefLabel
Ravi S Pandey
@es
Ravi S Pandey
@nl
Ravi S Pandey
@sl
Ravi S. Pandey
@en
P106
P1153
35305607900
36106443700
P21
P31
P496
0000-0002-8735-3954
P569
2000-01-01T00:00:00Z